Search ( Ctrl + / )

ISRG

Intuitive Surgical

ISRGNASDAQ

$561.63

-1.97

0.35%

Last Updated: May 19, 20:00

ISRG Financials

Search ( Ctrl + / )

ISRG

Intuitive Surgical

ISRGNASDAQ

$561.63

-1.97

0.35%

Last Updated: May 19, 20:00

ISRG Financials

	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Statement Date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Revenue	2.25B	2.04B	2.01B	1.89B	1.93B	1.74B	1.76B	1.70B
Cost of Revenue	795.70M	664.20M	637.20M	645.20M	650.90M	576.50M	584.00M	583.20M
Gross Profit	1.46B	1.37B	1.37B	1.25B	1.28B	1.17B	1.17B	1.11B
Gross Profit Ratio	0.65	0.67	0.68	0.66	0.66	0.67	0.67	0.66
Research and Development Expenses	316.20M	286.00M	280.10M	284.50M	260.10M	249.40M	244.40M	244.90M
General and Administrative Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling and Marketing Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Expenses	0.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	879.60M	796.60M	805.40M	776.00M	827.20M	701.40M	708.70M	725.40M
Cost and Expenses	1.68B	1.46B	1.44B	1.42B	1.48B	1.28B	1.29B	1.31B
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-28.70M
Depreciation and Amortization	140.90M	116.20M	111.80M	109.30M	123.20M	108.60M	97.30M	92.70M
EBITDA	719.00M	693.50M	679.10M	578.70M	573.40M	574.40M	463.20M	387.60M
EBITDA Ratio	0.32	0.34	0.34	0.31	0.30	0.33	0.26	0.23
Operating Income	578.10M	577.30M	567.30M	469.40M	450.20M	465.80M	365.90M	294.90M
Operating Income Ratio	0.26	0.28	0.28	0.25	0.23	0.27	0.21	0.17
Total Other Income Expenses	90.40M	93.70M	87.20M	69.10M	65.70M	56.20M	133.30M	126.90M
Income Before Tax	668.50M	671.00M	654.50M	538.50M	515.90M	522.00M	499.20M	421.80M
Income Before Tax Ratio	0.30	0.33	0.33	0.28	0.27	0.30	0.28	0.25
Income Tax Expense	-35.20M	100.40M	123.00M	-8.90M	-94.80M	102.20M	73.20M	61.00M
Net Income	698.40M	565.10M	526.90M	544.90M	606.20M	415.70M	420.80M	355.30M
Net Income Ratio	0.31	0.28	0.26	0.29	0.31	0.24	0.24	0.21
EPS	1.95	1.59	1.48	1.54	1.72	1.18	1.20	1.01

	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Statement Date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023
Revenue	2.25B	2.04B	2.01B	1.89B	1.93B	1.74B	1.76B	1.70B
Cost of Revenue	795.70M	664.20M	637.20M	645.20M	650.90M	576.50M	584.00M	583.20M
Gross Profit	1.46B	1.37B	1.37B	1.25B	1.28B	1.17B	1.17B	1.11B
Gross Profit Ratio	0.65	0.67	0.68	0.66	0.66	0.67	0.67	0.66
Research and Development Expenses	316.20M	286.00M	280.10M	284.50M	260.10M	249.40M	244.40M	244.90M
General and Administrative Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling and Marketing Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Expenses	0.00	0.00	1.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses	879.60M	796.60M	805.40M	776.00M	827.20M	701.40M	708.70M	725.40M
Cost and Expenses	1.68B	1.46B	1.44B	1.42B	1.48B	1.28B	1.29B	1.31B
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-28.70M
Depreciation and Amortization	140.90M	116.20M	111.80M	109.30M	123.20M	108.60M	97.30M	92.70M
EBITDA	719.00M	693.50M	679.10M	578.70M	573.40M	574.40M	463.20M	387.60M
EBITDA Ratio	0.32	0.34	0.34	0.31	0.30	0.33	0.26	0.23
Operating Income	578.10M	577.30M	567.30M	469.40M	450.20M	465.80M	365.90M	294.90M
Operating Income Ratio	0.26	0.28	0.28	0.25	0.23	0.27	0.21	0.17
Total Other Income Expenses	90.40M	93.70M	87.20M	69.10M	65.70M	56.20M	133.30M	126.90M
Income Before Tax	668.50M	671.00M	654.50M	538.50M	515.90M	522.00M	499.20M	421.80M
Income Before Tax Ratio	0.30	0.33	0.33	0.28	0.27	0.30	0.28	0.25
Income Tax Expense	-35.20M	100.40M	123.00M	-8.90M	-94.80M	102.20M	73.20M	61.00M
Net Income	698.40M	565.10M	526.90M	544.90M	606.20M	415.70M	420.80M	355.30M
Net Income Ratio	0.31	0.28	0.26	0.29	0.31	0.24	0.24	0.21
EPS	1.95	1.59	1.48	1.54	1.72	1.18	1.20	1.01